Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis.
Swartz RD, Starmann B, Horvath AM, Olson SC, Posvar EL.
Swartz RD, et al.
J Clin Pharmacol. 1990 Dec;30(12):1136-41. doi: 10.1002/j.1552-4604.1990.tb01857.x.
J Clin Pharmacol. 1990.
PMID: 2273086
Free article.
Overall, quinapril was well tolerated by these CAPD patients, with mild and transient side effects, not unexpected in this clinical setting, which included pruritus, headache, nausea, and cough. ...The elimination half-life of quinaprilat was markedly prolonged when …
Overall, quinapril was well tolerated by these CAPD patients, with mild and transient side effects, not unexpected in this clinical s …